The trajectory of Viagra presents a complex case for investors in the pharmaceutical sector. While initially a blockbuster success, creating huge profits, the intellectual property expiration and the subsequent entry https://pharma604097.theblogfairy.com/40548514/sildenafil-and-big-pharma-a-risky-investment